Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-5945
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial ; volume:17 ; number:1 ; day:8 ; month:5 ; year:2017 ; pages:1-7 ; date:12.2017
BMC dermatology ; 17, Heft 1 (8.5.2017), 1-7, 12.2017
- Schlagwort
-
Hautkrankheit
Dermatologie
- Urheber
-
Atalay, Selma
- Beteiligte Personen und Organisationen
-
van den Reek, Juul M. P. A.
van Vugt, Lieke J.
Otero, Marisol E.
van de Kerkhof, Peter C. M.
den Broeder, Alfons A.
Kievit, Wietske
De Jong, Elke M. G. J.
SpringerLink (Online service)
- DOI
-
10.1186/s12895-017-0057-6
- URN
-
urn:nbn:de:1111-20170520248
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Atalay, Selma
- van den Reek, Juul M. P. A.
- van Vugt, Lieke J.
- Otero, Marisol E.
- van de Kerkhof, Peter C. M.
- den Broeder, Alfons A.
- Kievit, Wietske
- De Jong, Elke M. G. J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Through the looking glass: understanding non-inferiority
Safe birth in cultural safety in southern Mexico: a pragmatic non-inferiority cluster-randomised controlled trial
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
Evidence-based sizing of non-inferiority trials using decision models
Superiority and non-inferiority: two sides of the same coin?
Phase IV non-inferiority trials and additional claims of benefit
Through the looking glass: understanding non-inferiority
Safe birth in cultural safety in southern Mexico: a pragmatic non-inferiority cluster-randomised controlled trial
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
Evidence-based sizing of non-inferiority trials using decision models
Superiority and non-inferiority: two sides of the same coin?
Phase IV non-inferiority trials and additional claims of benefit
Through the looking glass: understanding non-inferiority
Safe birth in cultural safety in southern Mexico: a pragmatic non-inferiority cluster-randomised controlled trial
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
Evidence-based sizing of non-inferiority trials using decision models
Superiority and non-inferiority: two sides of the same coin?